Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :
‘Experienced in working across different company stages’, Morrison Foerster’s emerging companies practice is also lauded for its ability to ’mentor inexperienced management teams’. Primarily sought after by start-ups and investors in the technology sector, where it can join up with the wider firm’s top-tier industry offering, it also demonstrates strong activity in the life sciences, and food and beverage arenas. The team added a raft of new clients during 2023/24 on the back of of a series of high-profile lateral hires. Most notably, new department co-chair Peter Fusco joined in New York from Goodwin, while ‘impeccable lawyer’ Chuck Cotter arrived in Denver from Holland & Hart LLP. The department is additionally co-led from San Francisco by high-profile industry specialist Michael Glaser, whose ’counsel is always incisive and on point’, and Murray Indick, who provides full-spectrum advice to start-ups, growth companies, and investors. In Palo Alto, Timothy Harris is noted for his advice to companies and investors on venture capital financings, corporate governance, and technology development. Jim Krenn is an accomplished partner in San Diego.
L’éditorial du Legal 500
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
- ‘The team has been exceptional. We had the benefit of great solutions for our start-up from the day we incorporated, delivered at a pace, which matched our own breakneck speed, without any hiccups or delays.’
- ‘The practice is a reflection of Michael Glaser, its outstanding co-chair. The team is extremely professional, responsive, and coordinated. Under Michael's expert guidance, it delivers a very high standard of service and advice. As a founder and start-up CEO, I would recommend it without reservation.’
Clients clés
- 9amHealth
- Aliment Capital
Points forts
- Advised start-up Hume AI on its $50m stock financing.
- Advised Rakuten Medical on its $119m stock financing.